Clinical & Experimental Metastasis

Papers
(The TQCC of Clinical & Experimental Metastasis is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis114
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches51
LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression34
The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria26
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics26
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics26
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption24
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG24
Oncolytic intralesional therapy for metastatic melanoma24
Preoperative embolization of renal cell carcinoma metastases to the bone prior to stabilization procedures does not result in reduction in intraoperative blood loss23
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection23
High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions22
Axillary nodal staging in breast cancer: what have we learned?21
Cell blebbing novel therapeutic possibilities to counter metastasis20
Topography and probability diagram of cervical and intra-parotid lymph node metastasis in parotid gland cancer19
Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis18
Correction: CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells17
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations17
Therapy resistance and metastasis16
Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer16
Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer16
Current preclinical models of brain metastasis15
CT-based deep learning model: a novel approach to the preoperative staging in patients with peritoneal metastasis15
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis14
Tumor microenvironment dynamics in oral cancer: unveiling the role of inflammatory cytokines in a syngeneic mouse model14
Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade14
Nectin-4 is frequently expressed in primary salivary gland cancer and corresponding lymph node metastases and represents an important treatment-related biomarker14
Etiology and treatment of cancer-related secondary lymphedema13
Efficacy and safety of PARPis combined with an ICIs for advanced or metastatic triple-negative breast cancer: a single-arm meta-analysis13
Correction: SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells13
Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations12
Histopathological growth patterns of neuroendocrine tumor liver metastases12
The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study12
Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis12
Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK111
Should EUS-FNA be considered also for the diagnosis of peripheral small pulmonary lesions?11
‘Sandwich treatment’ for posterior fossa brain metastases with volume larger than 4cm3: a multicentric retrospective study10
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation10
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results10
Correction: Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival9
Impact of time-of-day administration of immunotherapy on survival in metastatic renal cell carcinoma: the MOUSEION-09 meta-analysis9
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER29
Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics9
Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis9
Multi-institutional study using sbrt to treat mediastinal and hilar lymphadenopathy9
0.61227703094482